Skip to main content
$13.08 -$0.39 (-2.9%)

04:00 PM EST on 01/14/22

Array BioPharma, Inc. (NASDAQ:ARRY)

CAPS Rating: 5 out of 5

A biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat life threatening and debilitating diseases.

Current Price $13.08 Mkt Cap $2.0B
Open $13.40 P/E Ratio 0.00
Prev. Close $13.08 Div. (Yield) $0.00 (0.0%)
Daily Range $12.87 - $13.62 Volume 3,571,940
52-Wk Range $12.72 - $52.76 Avg. Daily Vol. 3,012,850

Caps

How do you think NASDAQ:ARRY will perform against the market?

Add Stock to CAPS Watchlist

All Players

253 Outperform
17 Underperform
 

All-Star Players

34 Outperform
1 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:ARRY Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

Aiming (< 20)
Submitted August 21, 2015

Many cancer medicine on trial. strong tieup with Astra for selling and research support. loss recovered compared to last year

zzlangerhans (98.93)
Submitted April 25, 2012

It's rather dangerous to red thumb a beaten down cancer or hepatitis biotech, because each one has a finite possibility of rising from the ashes like a Phoenix (or a Pharmasset or Pharmacyclics). Once the market anoints a developmental drug as the… More

NASDAQ:ARRY VS S&P 500 (SPY)

Fools bullish on NASDAQ:ARRY are also bullish on:

Recent Community Commentary

Read the most recent pitches from players about ARRY.

Recs

0
Member Avatar nverdurmen (< 20) Submitted: 10/1/2021 6:04:01 PM : Outperform Start Price: $18.55 NASDAQ:ARRY Score: -36.93

Solar industry

Recs

0
Member Avatar Kentuckyfarmer (< 20) Submitted: 8/12/2021 9:17:45 PM : Outperform Start Price: $16.93 NASDAQ:ARRY Score: -27.16

Finally has things going in the right direction. Had some issues with supply chain in Q1 2021 but seems to have that taken care of and ready to move forward.

Recs

1
Member Avatar Aiming (< 20) Submitted: 8/21/2015 8:49:14 AM : Outperform Start Price: $5.15 NASDAQ:ARRY Score: +23.21

Many cancer medicine on trial. strong tieup with Astra for selling and research support. loss recovered compared to last year

Leaderboard

Find the members with the highest scoring picks in ARRY.

Score Leader

Haugurafpeningum

Haugurafpeningum (28.68) Score: +1,593.44

The Score Leader is the player with the highest score across all their picks in ARRY.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
cnwarner < 20 2/6/2007 Underperform 5Y $13.00 +0.46% +241.08% +240.62 0 Comment
1under5out 30.36 7/20/2007 Underperform 5Y $11.69 +11.72% +215.85% +204.13 0 Comment
UncleSachse < 20 10/21/2009 Outperform 1Y $2.09 +524.88% +326.21% +198.67 0 Comment
wes29 47.24 6/10/2011 Outperform 3M $2.40 +444.17% +260.68% +183.48 0 Comment
jettyjett 58.78 10/10/2014 Outperform 5Y $3.15 +314.60% +141.07% +173.53 0 Comment
EvilUnicorn 32.27 11/17/2009 Outperform 5Y $2.21 +492.29% +319.02% +173.27 0 Comment
Playa14 < 20 9/6/2016 8/11/2021 Outperform 5Y $3.52 +271.02% +112.50% +158.52 0 Comment
boardwalken65 30.26 2/10/2012 Outperform 3M $2.65 +392.83% +246.48% +146.35 0 Comment
aerialist 67.47 8/16/2016 Outperform 3Y $3.65 +257.81% +112.60% +145.21 0 Comment
SFTuffy 70.26 9/9/2016 Outperform 5Y $3.64 +258.79% +114.20% +144.60 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for ARRY.